nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoxetate—ABCC3—Cyclosporine—focal segmental glomerulosclerosis	0.468	0.507	CbGbCtD
Gadoxetate—SLCO1B1—Cyclosporine—focal segmental glomerulosclerosis	0.242	0.262	CbGbCtD
Gadoxetate—ABCC2—Cyclosporine—focal segmental glomerulosclerosis	0.213	0.231	CbGbCtD
Gadoxetate—Pharyngeal oedema—Cyclosporine—focal segmental glomerulosclerosis	0.0057	0.0788	CcSEcCtD
Gadoxetate—Gadofosveset trisodium—ALB—focal segmental glomerulosclerosis	0.00531	1	CrCbGaD
Gadoxetate—Renal tubular necrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00456	0.063	CcSEcCtD
Gadoxetate—Swelling face—Cyclosporine—focal segmental glomerulosclerosis	0.00342	0.0473	CcSEcCtD
Gadoxetate—Coagulopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00209	0.0289	CcSEcCtD
Gadoxetate—Feeling hot—Cyclosporine—focal segmental glomerulosclerosis	0.00208	0.0287	CcSEcCtD
Gadoxetate—Abscess—Cyclosporine—focal segmental glomerulosclerosis	0.00206	0.0284	CcSEcCtD
Gadoxetate—Tingling sensation—Cyclosporine—focal segmental glomerulosclerosis	0.00203	0.028	CcSEcCtD
Gadoxetate—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.00179	0.0248	CcSEcCtD
Gadoxetate—Creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00171	0.0236	CcSEcCtD
Gadoxetate—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.00155	0.0214	CcSEcCtD
Gadoxetate—Blood urea increased—Cyclosporine—focal segmental glomerulosclerosis	0.00154	0.0213	CcSEcCtD
Gadoxetate—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.0195	CcSEcCtD
Gadoxetate—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.00132	0.0183	CcSEcCtD
Gadoxetate—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00124	0.0172	CcSEcCtD
Gadoxetate—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.0169	CcSEcCtD
Gadoxetate—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00111	0.0153	CcSEcCtD
Gadoxetate—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.0142	CcSEcCtD
Gadoxetate—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.0141	CcSEcCtD
Gadoxetate—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.0139	CcSEcCtD
Gadoxetate—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.000996	0.0138	CcSEcCtD
Gadoxetate—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.000983	0.0136	CcSEcCtD
Gadoxetate—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.000899	0.0124	CcSEcCtD
Gadoxetate—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.000896	0.0124	CcSEcCtD
Gadoxetate—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.000894	0.0123	CcSEcCtD
Gadoxetate—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.000886	0.0122	CcSEcCtD
Gadoxetate—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00082	0.0113	CcSEcCtD
Gadoxetate—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000814	0.0112	CcSEcCtD
Gadoxetate—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000804	0.0111	CcSEcCtD
Gadoxetate—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00076	0.0105	CcSEcCtD
Gadoxetate—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000742	0.0103	CcSEcCtD
Gadoxetate—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000738	0.0102	CcSEcCtD
Gadoxetate—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.000734	0.0101	CcSEcCtD
Gadoxetate—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.000731	0.0101	CcSEcCtD
Gadoxetate—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.000702	0.0097	CcSEcCtD
Gadoxetate—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.000698	0.00964	CcSEcCtD
Gadoxetate—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.000671	0.00927	CcSEcCtD
Gadoxetate—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.000667	0.00922	CcSEcCtD
Gadoxetate—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000661	0.00913	CcSEcCtD
Gadoxetate—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.000655	0.00904	CcSEcCtD
Gadoxetate—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000642	0.00887	CcSEcCtD
Gadoxetate—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00064	0.00884	CcSEcCtD
Gadoxetate—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000622	0.00859	CcSEcCtD
Gadoxetate—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.000617	0.00853	CcSEcCtD
Gadoxetate—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000607	0.00838	CcSEcCtD
Gadoxetate—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000604	0.00835	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000602	0.00832	CcSEcCtD
Gadoxetate—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000599	0.00828	CcSEcCtD
Gadoxetate—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000593	0.00819	CcSEcCtD
Gadoxetate—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000581	0.00803	CcSEcCtD
Gadoxetate—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000581	0.00803	CcSEcCtD
Gadoxetate—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000578	0.00798	CcSEcCtD
Gadoxetate—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00057	0.00788	CcSEcCtD
Gadoxetate—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000565	0.0078	CcSEcCtD
Gadoxetate—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000562	0.00776	CcSEcCtD
Gadoxetate—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000554	0.00765	CcSEcCtD
Gadoxetate—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000522	0.00721	CcSEcCtD
Gadoxetate—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000518	0.00716	CcSEcCtD
Gadoxetate—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000505	0.00698	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000502	0.00693	CcSEcCtD
Gadoxetate—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000501	0.00692	CcSEcCtD
Gadoxetate—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000497	0.00687	CcSEcCtD
Gadoxetate—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000479	0.00662	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000475	0.00657	CcSEcCtD
Gadoxetate—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000462	0.00638	CcSEcCtD
Gadoxetate—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00046	0.00635	CcSEcCtD
Gadoxetate—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00046	0.00635	CcSEcCtD
Gadoxetate—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000428	0.00592	CcSEcCtD
Gadoxetate—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000417	0.00576	CcSEcCtD
Gadoxetate—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000411	0.00568	CcSEcCtD
Gadoxetate—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000398	0.00549	CcSEcCtD
Gadoxetate—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000384	0.00531	CcSEcCtD
Gadoxetate—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00037	0.00511	CcSEcCtD
Gadoxetate—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000367	0.00506	CcSEcCtD
Gadoxetate—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000366	0.00506	CcSEcCtD
Gadoxetate—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000364	0.00503	CcSEcCtD
Gadoxetate—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000345	0.00477	CcSEcCtD
